Photo of Radek Skoda from biomedizin.unibas.ch
Jun 18, 2024, 02:57
Skoda: clonal evolution of Myeloproliferative Neoplasms
Talha Badar, Assistant Professor at Mayo Clinic Comprehensive Cancer Center shared on X:
“Skoda: clonal evolution of MPN, pre-CHIP—> CHIP—>MPN
1) concurrent mutation e.g. DNMT3A confer resistance to therapy
2) pegIFN most efficient way to decrease mutation allelic burden in MPN
3) pegIFN in combination with AZA may overcome concurrent resistant mutation in MPN.”
Source: Talha Badar/X
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 29, 2025, 17:57
Mar 29, 2025, 17:40
Mar 29, 2025, 17:30
Mar 29, 2025, 17:14
Mar 29, 2025, 17:00
Mar 29, 2025, 16:53